Featured Interview: CEO Dr. Carl Schwartz of Precision Therapeutics Inc. (NASDAQ: AIPT)

Featured Interview: CEO Dr. Carl Schwartz of Precision Therapeutics Inc. (NASDAQ: AIPT)

CEO Dr. Carl Schwartz of Precision Therapeutics Inc. (NASDAQ: AIPT), returns to Stock Day to talk in detail about multiple wholly owned divisions, including Skyline Medical, Tumor Genesis, and Helomics.

The CEOs interviewed on the Stock Day Podcast did not incur any charges for their time with Uptick Newswire CEO Everett Jolly. Contact us at (602) 441-3474 if you would like further information.

Close Menu

SIGN UP FOR THE EMAIL NEWSLETTER

The latest in micro-cap news and podcasts, straight to your inbox.

We won't ever spam!